相关实验视频
Updated: Jul 20, 2025
16:11
Implantation of the Syncardia Total Artificial Heart
Published on: July 18, 2014
35.3K
整体人工心脏:我们一直在哪里,我们现在在哪里,我们要去哪里?
Francisco A Arabía1,2, Catherine Friederich Murray3
1Advanced Heart Program, Banner - University Medical Group Phoenix, Phoenix, USA.
Indian journal of thoracic and cardiovascular surgery
|August 1, 2023
概括
整体人工心脏 (TAH) 是关键的替代品,因为供体心脏对于末期心力衰竭仍然有限. 目前正在进行的研究和临床改进表明,TAHs在治疗心力衰竭方面具有前景.
科学领域:
- 心血管医学 心血管医学
- 生物医学工程 生物医学工程
- 移植科学 移植科学
背景情况:
- 在全球范围内,末期心力衰竭的发病率和患病率不断上升.
- 移植供体心脏可用性的重大限制.
- 迫切需要其他先进的治疗方案.
研究的目的:
- 审查整体人工心脏 (TAH) 的历史发展和当前状态.
- 突出TAH技术的持续进展和未来方向.
- 评估TAHs在管理末期心力衰竭中的演变作用.
主要方法:
- 审查关于TAH发展的历史数据和文献.
- 对当前TAH模型和植入结果的分析.
- 讨论TAHs作为桥梁移植和目的地治疗.
主要成果:
- 塔赫发展有着一个长达一个世纪的历史,不断创新.
- 改进的TAH模型表明死亡率和发病率下降.
- 在精选的患者群体和高体积中心成功应用TAHs.
结论:
- 整体人工心脏是对末期心力衰竭的重要和先进的解决方案.
- TAHs的未来是有希望的,正在进行的研究提高了它们的有效性.
- TAHs提供了一个可行的选择,用于桥梁移植和目的地治疗.
相关概念视频
01:22Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
01:29Cardiomyopathy V: Interprofessional Care
16
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16